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We isolated an 8 kDa mycobacterial hypothetical protein, Rv3423.1,
from the chromatin of human macrophages infected with Mycobac-
terium tuberculosis H37Rv. Bioinformatics predictions followed by
in vitro biochemical assays with purified recombinant protein showed
that Rv3423.1 is a novel histone acetyltransferase that acetylates histone
H3 at the K9/K14 positions. Transient transfection of macrophages con-
taining GFP-tagged histone H1 with RFP-tagged Rv3423.1 revealed that
the protein co-localizes with the chromatin in the nucleus.
Co-immunoprecipitation assays confirmed that the Rv3423.1–histone
interaction is specific. Rv3423.1 protein was detected in the culture fil-
trate of virulent but not avirulent M. tuberculosis. Infection of macro-
phages with recombinant Mycobacterium smegmatis constitutively
expressing Rv3423.1 resulted in a significant increase in the number of
intracellular bacteria. However, the protein did not seem to offer any
growth advantage to free-living recombinant M. smegmatis. It is highly
likely that, by binding to the host chromatin, this histone acetyltrans-
ferase from M. tuberculosis may manipulate the expression of host genes
involved in anti-inflammatory responses to evade clearance and to sur-
vive in the intracellular environment.
Introduction
Tuberculosis (TB) is caused by Mycobacterium tuber-
culosis (MTB), an intracellular human pathogen that is
disseminated through air. TB has been a prominent
human disease for several thousand years. The latest
report from the World Health Organization revealed
that 9.6 million people developed TB in 2014, and it
caused 1.5 million deaths [1]. An important challenge
in the study of MTB is to understand how this bac-
terium escapes elimination by the immune system of
the host. When the pathogen enters the lungs of a
susceptible person, MTB succeeds in countering the
defense mechanisms of the alveolar macrophages, and
eventually manages to survive and multiply in the very
cells that are designated to eliminate the bacterium.
The strategies used by the pathogen are being intensely
investigated in many laboratories, and consequently
much is known now about the tactics employed by
intracellular MTB to tackle host defense mechanisms
and cause TB. Dissecting the mechanisms by which
intracellular pathogens regulate host gene expression
Abbreviations
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for their own advantage is crucial in developing meth-
ods to control the diseases caused by them. Regula-
tion of gene expression in eukaryotic cells is brought
about by the concerted activation and repression of
transcription through chromatin remodeling and
modifications that control the accessibility of DNA
regulatory sequences to transcription factors [2]. Post-
translational modifications of histones (methylation,
acetylation, phosphorylation, ubiquitination, sumoyla-
tion, ADP-ribosylation, etc.) modulate sequence-
specific DNA–protein interactions [3]. Chromatin
modification as a mechanism by which intracellular
bacteria modify their host environment has gained
considerable attention in the recent past. Several bac-
terial pathogens, such as Listeria monocytogenes [4],
Clostridium perfringens [5], Streptococcus pneumoniae
[5], Helicobacter pylori [6] and Anaplasma phagocy-
tophilum [7], are known to cause epigenetic modifica-
tions to manipulate host responses associated with
inflammation and immunity, which play a role in pro-
gression of the disease. Recently, such bacterial fac-
tors that act directly in the nucleus have been named
‘nucleomodulins’ [8]. Infection by MTB has been
shown to bring about changes in gene expression in
the host macrophages, leading to induction or subver-
sion of several immunomodulatory pathways [9,10].
We hypothesized that at least some of these changes
may be caused by chromatin modifications induced
directly by some products of the intracellular patho-
gen, or indirectly by recruitment of host chromatin-
modifying enzymes by some bacterial factors. Such
pathogenically induced reprogramming of host gene
expression may either augment or diminish the host’s
defense mechanisms, depending on which direction
the equilibrium shifts. Although MTB has been
reported to cause chromatin remodeling in macro-
phages [11,12], the identity and function of the bacte-
rial or cellular component(s) involved in this process
are largely unknown. Here we report the isolation
and identification of one such mycobacterial factor
that directly binds to the host chromatin and causes
hyperacetylation of histone H3 to up-regulate gene
expression. We infected macrophages with MTB
H37Rv, immunoprecipitated the chromatin using anti-
body against histone H3, and analyzed the chro-
matin-bound proteins by 2D gel electrophoresis
followed by LC/MS/MS. A unique protein present in
the chromatin complex of infected macrophages was
identified as Rv3423.1, an hypothetical protein of
8.4 kDa. By homology modeling and subsequent
in vitro assays, we demonstrated that this protein pos-
sesses histone acetyltransferase activity (HAT) on his-
tone H3 at the K9/K14 positions.
Results
Growth and survival of M. tuberculosis in human
macrophages
THP-1-derived macrophages were infected at a multi-
plicity of infection of 20 MTB bacilli per cell. Inter-
nalization of bacteria by macrophages was confirmed
by confocal microscopy (Fig. 1A) using MTB express-
ing GFP. Expression of host CORO1A, a well estab-
lished marker for viable intracellular mycobacteria
[13], was analyzed by quantitative PCR. The levels of
CORO1A were significantly higher at 24 h than at 12
h postinfection in macrophages containing live bacte-
ria, confirming that the intracellular mycobacteria
were viable (Fig. 1B). Use of heat-killed bacteria did
not cause any increase in the levels of CORO1A in
macrophages.
MTB hypothetical protein Rv3423.1 binds to the
chromatin in infected macrophages
Using a modified ChIP protocol (mChIP) [14,15], we
immunoprecipitated the chromatin of infected as well
as non-infected macrophages with antibody against
histone H3. Upon resolving the immunoprecipitates by
2D gel electrophoresis, one distinct spot was observed
in the infected sample, but not in the uninfected sam-
ple (Fig. 1C). The MALDI-TOF mass spectrometry
profile and peptide mass fingerprint of this protein are
shown in Fig. 2A,B. Mascot database search using
-NCBI-nr (National Center for Biotechnology Infor-
mation-non redundant) protein database (www.matrix
science.com) of the spot identified it as mycobacterial
hypothetical protein MT3532.1 in MTB CDC1551,
whose corresponding number in MTB H37Rv is
Rv3423.1. The Rv3423.1 protein has 76 amino acids
and a predicted molecular mass of 8.4361 kDa. The
amino acid sequence of the protein was submitted to
the UNIPROT protein database (http://www.unipro-
t.org/uniprot/P9WKY5). A BLASTn search revealed
that the full-length gene is present in all strains of
MTB, and also in some members of the MTB com-
plex, namely Mycobacterium canetti, Mycobac-
terium bovis and Mycobacterium africanum, with 100%
homology. However, it is absent in fast-growing non-
pathogenic Mycobacterium smegmatis.
In silico structure modeling and function
prediction
The bioinformatics protocol that we employed is illus-
trated in Fig. 3A. A FASTA search using the
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Sequence Annotated by Structure (SAS) tool [16]
resulted in identification of 1S5K, an aminoglycoside
6´-N-acetyltransferase [AAC(60)-ly] from Salmonella en-
terica, as a template, with a Smith–Waterman score of
70, 26.8% sequence identity and 100% query coverage.
Alternately, the fold recognition procedure resulted in
identification of 1J2Z, an UDP-N-acetylglucosamine
acyltransferase from Helicobacter pylori, as a template
with an @TOME [17] score of 88.65, 18.5% sequence
identity and 100% query coverage. Most hits resulting
from the @TOME search corresponded to acyltrans-
ferases, indicating that acyltransferase activity was the
most probable function. Nucleotide binding activity,
which is observed in acyl transferases [18], was also
suggested for this protein. From the FASTA and
@TOME results, we built 3D structure models for the
query sequence using 1S5K and 1J2Z as templates.
Thus the bioinformatics approaches suggested acyl
and acetyltransferases as possible templates, and trans-
ferase and nucleotide binding activities as possible
functions. The S. enterica template 1S5K showed the
presence of the ligand acetyl CoA at the binding site,
and thus the model built on 1S5K could be annotated
with the binding of acetyl CoA by structurally super-
posing the model onto the template and mapping the
binding site based on 1S5K (Fig. 3B). The AAC(60)-ly
of S. enterica is a HAT in addition to being an
aminoglycoside N-acetyltransferase [19]. There is a
Fig. 1. Photomicrographs of intracellular MTB, and 2D gel electrophoretograms of chromatin immunoprecipitates from uninfected and
infected macrophages. (A) Microscopic images of THP-1-derived macrophages infected with GFP-expressing MTB H37Rv at a multiplicity of
infection of 20:1. Cell nuclei were counter-stained with DAPI, and images were captured at 409 magnification. The images shown are
representatives of at least three experiments. Scale bar = 1 lm. (B) Levels of CORO1A transcripts in macrophages at 12 and 24 h post-
infection with live MTB H37Rv at a multiplicity of infection of 20:1. The mRNA expression levels were compared with those for uninfected
macrophages and macrophages infected with heat-killed MTB H37Rv. GAPDH was used as the endogenous control for quantitative PCR.
Values are means and standard deviations from three independent experiments. (C) 2D gel electrophoresis of immunoprecipitates from
uninfected and infected macrophages. THP-1-derived macrophages were infected with MTB H37Rv at a multiplicity of infection of 20:1.
Chromatin from uninfected macrophages (left) and infected macrophages (right) was immunoprecipitated using antibody against histone H3.
The proteins of the precipitate were subjected to isoelectric focusing using an IPG strip (linear pH gradient of 3-10) and subsequently
resolved by 10% SDS/PAGE. The protein spot S1 that is unique to infected macrophages was subjected to MALDI-TOF analysis.
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significant structural similarity between the bacterial
AAC(60)-ly and the Hpa2 HAT of yeast [19]. This
Salmonella enzyme is able to acetylate calf thymus
histone preparations and also the 21 amino acid
human histone H3 N-terminal peptide [19,20]. The
in silico prediction that Rv3423.1 protein has signifi-
cant sequence similarity with the S. enterica AAC
(60)-ly, and the fact that the protein was found
bound to the chromatin of infected macrophages,
strongly suggest HAT activity for the protein.
Rv3423.1 protein acts as a histone
acetyltransferase in vitro
The Rv3423.1 gene was amplified from the genomic
DNA of MTB H37Rv, cloned and expressed as an N-
terminal fusion in a pET SUMO expression system
(Invitrogen, Carlsbad, CA, USA) in Escherichia coli
(Fig. 4A). The fusion protein was purified using Ni-
NTA affinity chromatography, and was cleaved using
SUMO protease to yield the 8.4 kDa native protein
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Fig. 2. Protein identification by MALDI-TOF MS and peptide mass fingerprinting. (A) Peptide mass fingerprint of spot S1. The protein spot
was cut from the 2D gel, ‘in-gel’ trypsin-digested, purified, and analyzed by MALDI-TOF MS. (B) Protein and peptide summary report for
spot S1, generated by GPS Explorer. The observed masses were queried to the Mascot database. A protein score > 40 was considered to
indicate a statistically significant match (P < 0.05). The observed masses of six peptides significantly matched the theoretical masses of
tryptic digests of Rv3423.1 with a window of error of < 100 p.p.m.
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(Fig. 4B). The purified native protein was subjected to
various HAT assays to validate the in silico prediction.
Incorporation of the radioactive acetyl group on histones
from 3H-acetyl CoA
First we tested the HAT activity of the purified
Rv3423.1 protein using calf thymus histones as sub-
strate in the presence of 3H-labeled acetyl CoA. A sig-
nificant amount of radioactivity was incorporated into
calf thymus histones and retained on the P81 filter disc,
corresponding to 3H-acetyl groups added to histones,
when recombinant Rv3423.1 was used as the HAT
enzyme. The results also indicated that Rv3423.1 readily
acetylates histones in a concentration-dependent man-
ner (Fig. 5A). We used recombinant Rv2059 protein (a
periplasmic solute-binding protein of MTB), cloned and
purified under similar conditions, as a mock control.
When corresponding amounts of Rv2059 protein were
used in the assay, only a basal level of radioactivity was
retained on the filter disc, indicating that the high levels
of incorporation of the 3H-acetyl group onto histones
are indeed due to the HAT activity possessed by
Rv3423.1 protein.
Fig. 3. Homology modeling and prediction of the function of the Rv3423.1 protein. (A) The major steps involved in the modeling are shown in
blue boxes, tools/results that gave conclusive answers are shown in green boxes, and tools/results that did not give any clues are shown in red
boxes. Ribbon representations of the two probable models identified in the study are shown in separate panels with the PDB IDs of the
structures chosen as templates. (B) Structural superposition of template 1S5K (S. enterica AAC(60)-ly) and the model based on it. Both
structures are shown in ribbon representation (yellow for 1S5K and blue for the model). The binding pocket of acetyl CoA (sticks) is also shown.
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NADH generation
Histone acetylation by HATs releases free CoA, which
can reduce NAD to NADH with the help of pyruvate
dehydrogenase. In a cell-free assay, the NADH gener-
ated as a result of acetylation of a 21 amino acid N-
terminal peptide of histone H3 was quantified as an
indirect measure of HAT activity, and was expressed as
relative absorbance per nanogram of protein. The HAT
activity of Rv3423.1 increased gradually from the 1st
hour till the 4th hour (Fig. 5B). At the 3rd and 4th
hours, the extent of acetylation was comparable to that
by the positive control (HeLa nuclear extract). Recom-
binant Rv2059 protein, used as a mock control, did not
show any detectable HAT activity.
ELISA
Antibody against acetyl histone H3 (K9/14) specifically
detected the acetyl 21 amino acid N-terminal peptide
of histone H3. Our data strongly suggest that
Rv3423.1 protein is able to acetylate histone H3 at
positions K9 and K14 (Fig. 5C). The efficiency of
acetylation by Rv3423.1 protein was comparable to
that by the positive control (HeLa nuclear extract). In
addition, the acetyltransferase activity of the protein
was totally abolished by anacardic acid (10 lM), an
inhibitor of HAT activity.
Immuno dot blot
To confirm the above results, we performed an
immuno dot blot assay with antibody against acetyl
histone H3 (K9/K14). The acetylation was evident
when 250 ng protein was used in the reaction, which
correlated with the results from ELISA. The extent of
acetylation increased significantly when the amount of
the protein was doubled. In agreement with the ELISA
results, anacardic acid at 10 lM completely inhibited
the HAT activity of Rv3423.1 (Fig. 5D).
Together, the results from these four assays unequiv-
ocally prove that Rv3423.1 is a HAT.
Rv3423.1 gene is expressed by intracellular MTB
After infecting the macrophages with MTB H37Rv,
we analyzed the expression of the Rv3423.1 gene by
intracellular bacteria using quantitative PCR. We
found that expression of the gene marginally increased
(1.5-fold) from 12 to 24 h post-infection (Fig. 6). The
level of Rv3423.1 expression was found to not to
decrease up to 60 h, after which we were unable to fol-
low the expression due to death of infected cells.
Co-localization of Rv3423.1 protein with
chromatin
We co-transfected THP-1-derived macrophage cells with
constructs carrying histone H1–eGFP and Rv3423.1–
DsRed fusions, and analyzed the fluorescence by confo-
cal microscopy. As expected, H1–eGFP fluorescence
was exclusively localized in the nucleoplasm. Although
a significant amount of Rv3423.1 protein was found to
be present in the cytoplasm, it was also observed inside
the nucleus. To confirm its nuclear localization, we ana-
lyzed Z-stacked images of transfected cells, and found
that Rv3423.1–DsRed was present as large distinct spots
distributed randomly inside the nucleus against the uni-
form green fluorescence of the chromatin (Fig. 7). A
movie composed of stacked images clearly showed a 3D
distribution of the protein inside the nucleus of trans-
fected macrophages, in association with the chromatin
(Movie S1), which confirmed the co-localization.
Rv3423.1 physically interacts with histone H3
Using various in vitro assays, we have shown that
Rv3423.1 acetylates histone H3. To perform its HAT
activity, it is necessary that Rv3423.1 physically inter-
acts with histone H3. We performed a co-immunopre-
cipitation assay to demonstrate this interaction. The
protein complex was immunoprecipitated with
antibody against histone H3, and the bound proteins
were probed for the presence of Rv3423.1 by Western
analysis using antibodies raised against Rv3423.1
protein. The results clearly showed that Rv3423.1 is
Fig. 4. Over-expression of the Rv3423.1–SUMO fusion protein in
E. coli, and SUMO protease cleavage. (A) Over-expression of
SUMO-tagged Rv3423.1 after induction with isopropyl-b-D-
thiogalactopyranoside at 28 °C. Crude cell lysates (20 lg) were
resolved by SDS/PAGE. Lane 1, molecular weight markers; lane 2,
un-induced sample; lane 3, induced for 4 h; lane 4, induced for 8 h.
(B) The recombinant Rv3423.1–SUMO fusion protein was
subjected to cleavage of the tag by protease for 16 h, and native
protein was purified. Lane 1, recombinant fusion protein after
protease cleavage; lane 2, eluted native Rv3423.1 protein.
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associated with histone H3 (Fig. 8A) in infected cells.
Non-specific IgG antibodies did not co-precipitate the
Rv3423.1 protein. In a reverse analysis, we immuno-
precipitated the proteins of the lysate of infected cells
using antibodies against Rv3423.1, and the bound pro-
teins were probed using antibody against histone H3.
Antibodies against IgG were used as a non-specific
control. The result confirmed that Rv3423.1 protein of
MTB and histone H3 interact with each other in
MTB-infected macrophages (Fig. 8B).
Fig. 5. Rv3423.1 is a histone acetyltransferase in vitro. (A) Filter binding assay. The ability of the recombinant Rv3423.1 protein to
incorporate a 3H-labeled acetyl group into calf thymus core histones using radioactive acetyl CoA was measured by liquid scintillation
counting. The reaction mix was incubated at 37 °C for 30 min with various concentrations of the protein, ranging from 0 to 1000 ngmL1,
and the incorporated radioactivity trapped on the P81 filter was counted. A non-relevant recombinant mycobacterial protein (Rv2059) was
used as a mock control. Values are means  SEM from three independent experiments at each concentration. (B) Generation of NADH.
HAT substrates provided in the HAT assay kit were incubated with Rv3423.1 (250 ngmL1) at 37 °C for up to 4 h. HeLa cell nuclear extract
was used as a positive control. A non-relevant mycobacterial protein (Rv2059) was used as a mock control. Absorbance values at 450 nm
after background subtraction at four time points are plotted. Values are means  SEM from three independent experiments. (C) ELISA.
Histone H3 peptide substrate was incubated with Rv3423.1 protein (250 ngmL1) at 30 °C for 90 min. Acetyl histone H3 was detected
using antibody against acetyl H3 K9/K14. Non-acetyl histone H3, acetyl histone H3 and HeLa nuclear extract served as controls. Anacardic
acid (10 lM) is a HAT inhibitor. Absorbance values at 450 nm after background subtractions are plotted. Values are means  SEM from
three independent experiments. (D) Immuno dot blot. The reaction mix was prepared as described for the ELISA, and incubated at 30 °C for
90 min. The mix was then spotted onto poly(vinylidene difluoride) membrane and air-dried. The dot blot was probed using antibody against
acetyl H3 K9/K14 and alkaline phosphatase-conjugated secondary antibody. A representative image of three independent Western dot blots
is shown. Anacardic acid (10 lM) was used to inhibit HAT activity.
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Rv3423.1 is secreted by MTB H37Rv but not
H37Ra
We analyzed the cell lysates and culture filtrates from
mid-log phase cultures of aerobically grown MTB vir-
ulent strain H37Rv and avirulent strain H37Ra for the
presence of Rv3423.1 protein. Western blot analysis of
the H37Rv strain showed expression of the protein in
both the cell lysate as well as the culture filtrate
(Fig. 9A). In contrast, we were unable to detect
Rv3423.1 in the culture filtrates of H37Ra, even
though the protein was present in the lysate (Fig. 9B).
This suggests that H37Rv, but not H37Ra, is able to
secrete the protein into the extracellular environment.
Rv3423.1 expression enhances the intracellular
multiplication of recombinant M. smegmatis
Rv3423.1 was amplified from MTB H37Rv genomic
DNA and cloned into mycobacterial constitutive
expression vector pBEN. The recombinant plasmid
was introduced into M. smegmatis by electroporation,
and growth of the bacteria in Middlebrook 7H9 med-
ium was monitored by measuring the attenuance at
600 nm. Bacteria carrying the pBEN vector served as
the control. The growth patterns of both the bacteria
were the same, and both reached an attenuance at
600 nm of 0.6 (mid-log phase) in approximately 21 h,
and reached stationary phase at approximately 36 h
(Fig. 10A). A Western blot using antibodies against
Rv3423.1 confirmed the presence of the protein in the
cell lysate (Fig. 10B). To analyze whether the protein
provided any survival advantage to the intracellular
bacteria, we infected THP-1-derived macrophages with
M. smegmatis carrying Rv3423.1 in pBEN and
M. smegmatis carrying the vector alone. We harvested
and lysed the macrophages at regular intervals, and
plated the lysate on Middlebrook 7H10 agar medium.
During the initial phase, the number of recombinant
M. smegmatis increased significantly, to reach a maxi-
mum (1.4 9 104) at 6 h (approximately two genera-
tions), while the number of non-recombinant bacteria
increased only marginally (1.05 9 104, Fig. 10C).
However, after 6 h, both the recombinant and non-
recombinant bacteria started to die, and, in both cases,
the number of viable bacteria decreased to almost zero
at 48 h. Both recombinant and non-recombinant bacteria
were completely cleared by the macrophages in 3 days.
Discussion
The primary objective of this study was to search for
MTB effector proteins that enter the nucleus of the
macrophage after infection and directly interact with
the chromatin. We infected THP-1 human monocyte-
derived macrophage cells with virulent MTB H37Rv,
and immunoprecipitated the chromatin with antibody
against histone H3. As we were interested in identify-
ing proteins that interact with the chromatin rather
than with the DNA, we subjected the chromatin-asso-
ciated proteins to 2D gel electrophoresis, and looked
for spots that were uniquely present in the infected
samples. One of the prominent unique spots was sub-
jected to MALDI-TOF analysis, and was identified as
Fig. 6. Rv3423.1 is up-regulated at 24 h after infection. THP-1-
derived macrophages were infected with MTB H37Rv at a
multiplicity of infection of 20 : 1. The levels of Rv3423.1 transcript
inside infected macrophages were analyzed by quantitative PCR at
0, 6, 12 and 24 h after infection. The endogenous gene SigA
served as a control. Values are means  SEM from three
independent experiments performed in triplicate.
Fig. 7. Rv3423.1 co-localizes with histones inside the macrophage nucleus and interacts with histone H3. (A) THP-1-derived macrophages
were co-transfected with plasmids expressing eGFP-labeled histone H1 and DsRed-labeled Rv3423.1 by electroporation. The cells were
visualized by confocal microscopy 12 h post-transfection. All images were acquired at 409 magnification. Images are representatives of at
least three independent experiments. Scale bar = 1 lm. (B) Single cell showing GFP/DsRed co-localization. The arrow represents a 16 lm
region of interest for which the intensities of red and green colors have been plotted in (C). (C) Fluorescence intensities show co-incident peaks
from the red and green channels in (B), indicating co-localization. (D) Co-localization coeffiecients were calculated using NIS-ELEMENTS software;
The relative numbers of co-localizing pixels in each channel are expressed compared with the total number of pixels above threshold. The value
range is from 0 to 1, where 0 indicates no co-localization and 1 indicates that all pixels co-localize. All pixels above background are counted
irrespective of their intensity. Results were obtained from images acquired from at least three separate co-transfection experiments.
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MT3532.1, a hypothetical protein with a molecular
mass of 8.4361 kDa in MTB CDC1551, whose coun-
terpart in MTB H37Rv is Rv3423.1. Based on in silico
analyses, three probable activities, namely acyl/acetyl-
transferase, oxidoreductase and nucleotide binding,
were predicted for the protein. As the protein was
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originally isolated from the chromatin of infected cells,
and as acetyltransferase activity was predicted as the
most probable activity, we decided to test whether
Rv3423.1 possesses HAT activity. Using four assays,
i.e. a filter binding assay using radio-labeled
acetyl CoA, ELISA, NADH release and Western blot-
ting, we demonstrate that this protein is indeed a
HAT. Using antibodies against variously acetylated
lysines, we showed that Rv3423.1 acetylates histone
H3 at K9 and K14. Post-translational modifications of
histones such as acetylation of H3 and H4 are consid-
ered markers of gene expression, and are frequently
associated with active transcription [21]. Acetylation of
H3K9 and H3K14 occurs throughout the genome, and
is shown to have high correlation with each other, and
these modifications are referred to as ‘transcription-
linked’ histone marks [22,23]. We showed that anac-
ardic acid, a non-specific inhibitor of several known
HATs due to its structural similarity to acetyl CoA,
was able to inhibit the HAT activity of Rv3423.1,
which further confirms the function of this protein.
Fig. 8. Rv3423.1 associates with histone H3 in vivo. (A) THP-1-
derived macrophages were infected with MTB H37Rv, and the cell
extract was immunoprecipitated with histone H3 or rabbit non-
specific IgG coupled to Protein A beads and immunoblotted with
antibodies against Rv3423.1 (B) The cell extract was
immunoprecipitated with antibodies against Rv3423.1 or rabbit
non-specific IgG, and the immune complexes were subjected to
Western blotting with antibody against histone H3.
Fig. 9. Rv3423.1 is secreted by MTB H37Rv but not MTB H37Ra.
In vitro expression and secretion of Rv3423.1 were probed using
cell lysates and culture supernatants of MTB H37Rv and H37Ra.
Total protein concentrations were determined using the Bradford
assay, and 30 lg samples were subjected to SDS/PAGE and
Western blot analysis. Detection was performed using antibodies
against Rv3423.1.
Fig. 10. Rv3423.1 confers distinct a intracellular survival advantage
to recombinant M. smegmatis carrying the gene, but has no effect
on growth under free-living conditions. (A) Recombinant and non-
recombinant M. smegmatis were grown in Middlebrook 7H9
medium containing kanamycin (25 lgmL1), and the attenuance at
600 nm was recorded every 3 h up to 48 h. The results for three
independent experiments were similar. (B) Recombinant
M. smegmatis expresses Rv3423.1. Recombinant and non-
recombinant M. smegmatis were grown in Middlebrook 7H9
medium containing kanamycin (25 lgmL1) for up to 24 h, and
whole-cell lysates were probed for the presence of Rv3423.1 by
Western blotting, with detection using antibodies against
Rv3423.1. (C) THP-1-derived macrophages were infected with
M. smegmatis mc2155 transformed with recombinant pBEN vector
carrying Rv3423.1 or no insert as described in Experimental
procedures. Aliquots of infected cells were lysed with water at the
indicated time points up to 72 h. Serial dilutions from each time
point were plated on Middlebrook 7H10 agar plates containing
kanamycin (25 lgmL1), and incubated for 3–4 days at 37 °C. The
number of intracellular bacteria is shown as colony-forming units
per ml (CFUmL1) at various time points. Values are means  SD
from triplicate wells of a 96-well plate. Similar results were
obtained for three independent experiments.
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Until now, only very few MTB proteins have been
shown to modulate host gene expression by chromatin
remodeling/modification of the host genome. The
19 kDa lipoprotein LpqH and the 6 kDa early
secreted antigen ESAT6 are known to inhibit inter-
feron c-induced chromatin remodeling of the class II
transactivator CIITA that is involved in the class II
MHC processing pathway [24–27]. However, this
chromatin remodeling is an indirect process brought
about through interferon c-mediated signaling, and
may be Toll like receptor-dependent or independent.
Interestingly, two MTB proteins have been shown to
be localized in the host nucleus and directly induce
epigenetic modifications. Rv0256c enters the nucleus
with the help of a bipartite nuclear localization signal,
and inhibits NO production by specifically interacting
with the inducible nitric oxide synthase (iNOS)
promoter [28,29]. Rv2966c, a secreted DNA methyl-
transferase, has been shown to enter the nucleus
of macrophages and bind specific DNA sequences,
methylate cytosines in a non-CpG context, and inter-
act with methylated histones H3 and H4 [30].
To demonstrate that Rv3423.1 enters the nucleus to
bind to the chromatin, we tagged the MTB protein
and histone H1 with fluorescent proteins, and analyzed
the images using confocal microscopy. GFP-tagged
histone H1 provided a uniform green background con-
fined to the interior of the nucleus. However, RFP-
tagged Rv3423.1 was found to be distributed through-
out the inside of the cells. To confirm that the protein
had entered the nucleus, we combined images from
sequential focal planes (Z-stacking) (Movie S1) as well
as co-localization analyses, which clearly showed that
the protein did enter the nucleus.
Given the ability of Rv3423.1 to acetylate histone
H3 in vitro, it is conceivable that the protein physically
interacts with histone H3 inside the nucleus to exert its
activity. Co-immunoprecipitation experiments clearly
showed that Rv3423.1 interacts with histone H3. This
interaction and subsequent transcriptional activation
may modulate pathways that regulate host immune
responses after MTB infection, and aid bacterial per-
sistence/survival. To the best of our knowledge, this is
the first evidence of a direct interaction between a bac-
terial HAT enzyme and the host chromatin.
It is interesting to note that Rv3423.1 lacks any
signal peptide for secretion from the bacterium. Viru-
lent MTB is known to secrete many small, highly
immunogenic proteins that lack classical signal
sequences, the most studied being ESAT6 [31]. This
protein is a major substrate of the ESX-1 type VII
secretion system, and is known to induce rupture of
phagosomal membranes to allow transport of many
mycobacterial effector proteins into the cytosol [31–
34]. We tested the culture supernatants of virulent as
well as avirulent strains of MTB for the presence of
Rv3423.1, and our findings suggest that this protein
is synthesized by both virulent and avirulent MTB
but is secreted only by virulent MTB. It has been
reported that the ESX-1 type VII secretion system is
impaired in avirulent H37Ra [35]. Therefore, it is pos-
sible that Rv3423.1 reaches the host cytoplasm after
phagosomal rupture, from where it is directed into
the nucleus.
Even though the protein was found inside the
nucleus, there is no evidence for any known nuclear
localization signal in the sequence. However, this is
not surprising as very few bacterial proteins possess a
well-defined classical monopartite or bipartite nuclear
localization signal [36,37]. There are also several
classes of proteins with a non-classical nuclear local-
ization signal that do not contain well-conserved
sequences [38]. It is likely that Rv3423.1, being a very
small protein (8.4 kDa), enters the nucleus on its own
or utilizes host proteins to hitchhike into the nucleus.
As Rv3423.1 is localized on the chromatin, we were
expecting it to be a ‘recruiter’ of host chromatin
remodeling complexes or chromatin-modifying
enzymes. To our surprise, however, it turned out to be
a histone-modifying enzyme in itself, rather than being
a facilitator that recruits host machinery to the chro-
matin.
The role of nucleomodulins in infection, virulence
and diseases caused by intracellular pathogens has
gained attention recently. In this study, we have
demonstrated that the MTB protein Rv3423.1 is a
HAT, enters the nucleus of macrophages, binds to the
chromatin, and acetylates H3 at the K9/14 positions.
Therefore, in all likelihood, this MTB HAT may regu-
late transcription of host genes whose products may
help the pathogen survive and multiply within the
macrophage, and hence may play a role in the disease
progression. At present, it is not clear whether this
protein helps the intracellular MTB directly by playing
a role in enhancing the survival/virulence, or whether
it is indirectly involved in suppressing the immune
response of the host. The role of this protein inside the
bacterium is also not known. As it is a lysine acetyl-
transferase, it may also acetylate bacterial proteins that
have yet to be identified. Although there is currently
no evidence of any protein with significant homology
to Rv3423.1, it would be interesting to look for pro-
teins with similar functions in other intracellular
pathogens. Because of its probable role in the regula-
tion of host genes, MTB HAT may constitute a novel
drug target or vaccine candidate. It is hoped that our
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study will stimulate a search for novel nucleomodulins
that form a new class of targets for therapeutic inter-
vention.
Experimental procedures
Infection of THP-1-derived macrophage cells with
MTB H37Rv
Human acute monocytic leukemia cell lines (THP-1) were
obtained from the National Centre for Cell Sciences (Pune,
India). Cells were routinely cultured in RPMI-1640 medium
supplemented with 10% fetal bovine serum, 2 mM L-gluta-
mine, 25 mM HEPES, 1.5 gL1 sodium bicarbonate, by
incubation at 37 °C in the presence of 5% CO2. Phorbol
12-myristate 13-acetate (Sigma-Aldrich, St. Louis, MO,
USA) at a final concentration of 20 ngmL1 was added to
the cells (3 9 106 per mL) for differentiation into macro-
phages. The virulent M. tuberculosis strain H37Rv, aviru-
lent strain H37Ra and non-pathogenic M. smegmatis
mc2155 were used in the study. All experiments with MTB
were performed in a Biosafety Level 3 (Standard usage)
facility at Rajiv Gandhi Centre for Biotechnology for safe
handling of the bacilli. Bacteria were grown in Middle-
brook 7H9 broth (Difco, Detroit, MI, USA) supplemented
with 10% oleate-albumin-dextrose-catalase (Becton Dickin-
son, Franklin Lakes, NJ, USA), 0.4% glycerol and 0.05%
Tween-80. The 1 mL culture was sonicated (20 pulses) in a
wave sonicator (Elmasonic, Singen, Germany) to disrupt
the clumps. The suspension was dispersed by aspirating five
times through a 24-gauge needle, followed by ten times
through a 30-gauge needle, and was allowed to stand for
5 min. The upper half of the suspension was then used for
the experiments. Bacteria were counted by measuring the
attenuance at a wavelength of 600 nm (0.2 units corre-
sponds to approximately 300 9 106 bacteria per ml), and
then harvested by centrifugation at 1000 g for 10 min,
washed with RPMI 1640 for 5 min at 1000 g at 25 C
and resuspended in the same medium. Further dilutions
were made to obtain a multiplicity of infection of 20 : 1 in
RPMI medium. Bacterial suspension was added to the
macrophages in fresh RPMI 1640 medium without fetal
bovine serum. Internalization of the bacteria was allowed
to proceed for 3 h at 37 °C and 5% CO2 in the humidified
incubator. Uninfected cells served as the negative control.
After internalization, the macrophages were washed three
times with PBS containing gentamycin (2.5 lgmL1) to
remove non-internalized bacteria. Fresh medium was added
to the cells before incubation at 37 °C for 24 h.
Visualization of infected macrophages
THP-1-derived macrophages were grown on glass coverslips
in 24-well plates (Tarsons, Kolkata, India) at a density of
2 9 105 cells per well. The cells were infected with mid-log
phase M. tuberculosis H37Rv expressing GFP (pBEN-GFP
plasmid) as described above. After incubation for 24 h, the
cells were washed briefly in PBS and then fixed in PBS con-
taining 4% paraformaldehyde for 15 min at 25 °C. The cells
were then washed twice with ice-cold PBS. For counter-stain-
ing, the cells were incubated with 40,6-diamidino-2 phenylin-
dole (DAPI) (0.1 lgmL1) in PBS/Tween for 5 min. The
cells were rinsed with PBS and smeared onto glass slides and
air-dried for 5 min. Coverslips were mounted on the smears
using a drop of 50% glycerol. The coverslips were sealed
with di-n-butyl phthalate in xylene (Sigma-Aldrich) mount to
prevent drying and movement under the microscope. The
cells were viewed under a confocal laser scanning microscope
(Nikon Eclipse Ti-S, Tokyo, Japan) at 409 magnification.
Images of bacteria were captured via the FITC channel (exci-
tation 490 nm, emission 525 nm), and the images of macro-
phage nuclei were captured in the DAPI channel (excitation
350 nm, emission 470 nm).
Viability of intracellular mycobacteria
Infection of macrophages with MTB was performed as
described above. Heat-killed bacteria were prepared by heat-
ing the culture at 80 °C for 2 h in a heating block. Total RNA
was isolated using an RNAspin mini kit (GE Healthcare,
Piscataway, NJ, USA) according to the manufacturer’s
instructions. cDNA was prepared from 0.5 lg total RNA
using a GoScriptTM reverse transcription system (Promega,
Madison, WI, USA). The relative expression ofCORO1A was
evaluated by quantitative real-time PCR using a SYBR Green
Supermix kit (Bio-Rad, Hercules, CA, USA). The PCR condi-
tions were as follows: 61 °C for 20 min, 95 °C for 4 min,
95 °C for 10 s, 63 °C for 30 s, 72 °C for 30 s (30 cycles), then
55–95 °C with a 0.5 °C increment (melting curve). Each sam-
ple was normalized to the level ofGAPDH transcript.
Modified chromatin immunoprecipitation
(mChIP)
The cells were treated with RPMI medium containing 1%
formaldehyde for 15 min at 25 °C to crosslink DNA and
proteins. Chromatin was prepared using a Bioruptor wave
sonicator (Diagenode, Seraing, Belgium). The pulse condi-
tions were 30 s on, 30 s off for 25 cycles at 4 °C. Whole-
cell lysate was prepared using 1 mL lysis buffer comprising
50 mM HEPES/KOH pH 7.5, 140 mM NaCl, 1 mM EDTA,
pH 8.0, 1% Triton X-100, 0.1% sodium deoxycholate,
0.1% SDS and protease inhibitor cocktail (Sigma-Aldrich).
The lysate was incubated with antibody against histone H3
(Abcam, Cambridge, UK) at 4 °C overnight on a rotating
platform at 40 rpm. Protein A Sepharose beads (Sigma-
Aldrich) were used for immunoprecipitation. Briefly, the
overnight sample was mixed with pre-blocked protein A
Sepharose beads, and the immunoprecipitate was pulled
down by incubating on a platform rotating at 40 rpm for
276 FEBS Journal 283 (2016) 265–281 ª 2015 FEBS
Histone acetyltransferase from M. tuberculosis L. Jose et al.
2 h at 4 °C. The beads were then removed by centrifuga-
tion at 1500 g for 5 min, and then washed three times with
1.0 mL of ice-cold ChIP washing buffer (10 mM Tris/Cl pH
8.0, 0.25 M LiCl, 0.05% IGEPAL CA-630 (Sigma- Aldrich)
and 0.5% sodium deoxycholate) at 1500 g at 4 °C. The
beads were then resuspended in ice-cold 2D rehydration/ly-
sis buffer, and incubated at 4 °C for 4 h on a rotating plat-
form. The beads were spun down at 1000 g at 4 °C, and
the supernatant was collected.
2D gel electrophoresis
The immunoprecipitates from infected and non-infected cells
were subjected to iso-electric focusing in a Multiphor II elec-
trophoresis system (GE Healthcare). The protein sample
(100 lg) was mixed with rehydration buffer to make up the
final volume to 125 lL, and applied to IPG strips (linear pH
gradient 3-10; GE Healthcare). The iso-electric focusing con-
ditions used were 500 V for 2 h, 1500 V for 1 h, and 3500 V
for 5 h, successively. Once the run was completed, the strips
were treated with equilibration solution (75 mM Tris/HCl
pH 8.8, 6 M urea, 30% v/v glycerol, 2% w/v SDS and
0.002% bromophenol containing 65 mM dithiothreitol), and
then incubated for 15 min in equilibration solution contain-
ing 135 mM iodoacetamide. Finally, the strips were briefly
rinsed with 5.0 mL SDS running buffer (25mM Tris/HCl pH
8.3, 250mM glycine, 0.1% w/v SDS) before proceeding to
the second dimension of separation in an 10% SDS/PAGE
gel, and subsequently stained with a mass spectrometry-com-
patible ProteoSilver staining kit (Sigma-Aldrich).
MALDI-TOF mass spectrometry
The proteins in the gels of infected and non-infected sam-
ples were compared manually, and the spots that appeared
on the gels containing infected samples but did not appear
on the gels containing non-infected samples were identified.
One such spot (S1) was excised from the gel and stored in
1% acetic acid. The spot was digested using Tosyl phenyla-
lanyl chloromethyl ketone-treated trypsin (Applied Biosys-
tems, Foster City, CA, USA), purified using a trypsin
profile IGD kit (Sigma-Aldrich), and then loaded onto an
Applied Biosystems 4800 MALDI TOF-TOF system to
generate the spectrum. Spectral acquisition was performed
using 4000 SERIES DATA EXPLORER software (Applied Biosys-
tems), and data analysis was performed using GPS EXPLORER
(Applied Biosystems) and Mascot. The most relevant hit
was identified and submitted to BLAST analysis, and the
protein/gene was identified.
Function prediction through bioinformatics
analysis
The query Rv3423.1 sequence (UNIPROT accession ID
P9WKY5, 76 amino acids long) was searched against the
Protein Data Bank using FASTA from the Sequence Anno-
tated by Structure (SAS) tool [16], in order to find tem-
plates that were homologous to the query. Sequence-based
function predictions were performed using the PFP (http://
kiharalab.org/web/pfp.php) and ProtFun (http://www.cbs.
dtu.dk/services/ProtFun/) tools. The query sequence was
checked for short sequence motifs and patterns using the
Prosite (prosite.expasy.org/) and Prints (http://www.bio
inf.manchester.ac.uk/dbbrowser/PRINTS/index.php) data-
bases. Further, fold recognition was performed to identify
fold templates using the @TOME (version 2.1) database [17].
Modeller (version 9) (https://salilab.org/modeller/) was used
to build 3D structure models for the query. Pymol
(www.pymol.org) was used for structure visualization and
generation of images.
Cloning, expression and purification of Rv3423.1
The Rv3423.1 gene was amplified from MTB H37Rv geno-
mic DNA using specific primers (Table 1). The PCR condi-
tions comprised a DNA denaturation step at 95 °C for
5 min, followed by 25 cycles at 95 °C for 30 s, 65 °C for
30 s and 72 °C for 45 s, and a final elongation step at 72 °C
for 5 min. The 231 bp PCR product was purified using an
Illustra GFX PCR DNA and gel band purification kit (GE
Healthcare). The PCR product was cloned into a linearized
Champion pET SUMO expression vector (Invitrogen). To
do this, the PCR product and vector were mixed in an
equimolar ratio and ligated overnight using T4 DNA ligase
at 20 °C. The resulting construct was then transformed into
One Shot Mach1TM T1 Phage-Resistant Chemically Com-
petent E. coli cells provided in the Champion pET SUMO
expression kit (Invitrogen). Positive clone selection was
based on kanamycin resistance. The identity of the con-
struct was confirmed by DNA sequencing. The Rv3423.1–
SUMO fusion construct was then transformed into One
Shot BL21(DE3) chemically Competent E. coli cells sup-
plied in the above-mentioned kit. Isopropyl-b-D-thiogalacto-
pyranoside was then added to a final concentration of 1 mM
to induce expression of the Rv3423.1–SUMO fusion. The
Table 1. List of primers used in the study.
Primer name Sequence (5’?3’)
Human quantitative PCR primers
GAPDH F AATGAAGGGGTCATTGATGG
GAPDH R AAGGTGAAGGTCGGAGTCAA
MTB Rv3423.1 whole-gene primers
Rv3423.1 F GTGTCGTTTGGCTTTCCGA
Rv3423.1 R CTACGCTCCCGTCAATTCATG
MTB quantitative PCR primers
SigA F CTCGGTTCGCGCCTACCTCA
SigA R GCGCTCGCTAAGCTCGGTCA
Rv3423.1 qF GCTTTCCGACATTCTCCC
Rv3423.1 qR AACCACCGAGCCACAG
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over-expressed fusion protein was purified under native con-
ditions using Ni-NTA agarose resin (Thermo Scientific,
Waltham, MA, USA). The purified protein was concen-
trated and buffer-exchanged using Amicon Ultra-15
centrifugal filter units (3 kDa molecular weight cut-off,
Millipore, Billerica, MA, USA). To cleave the fusion tag,
SUMO protease (Invitrogen) was added to the concentrated
fusion protein to a final concentration of 0.5 Ulg1. The
cleavage reaction was incubated at 16 °C, 40 rpm overnight.
The native protein was separated from the 69 His-tagged
SUMO protein by applying the cleaved sample to an Ni-
NTA spin column (Promega). The cleaved Rv3423.1 protein
was recovered from the flow-through fraction of the Ni-
NTA spin column, and was then concentrated and buffer
exchanged using Amicon Ultra-15 centrifugal filter units,
and its identity was confirmed using MALDI-TOF mass
spectroscopy.
Histone acetyltransferase assays
Filter binding assay
A filter binding assay was performed using P81 phosphocel-
lulose filter plates (Millipore). Microcentrifuge tubes con-
taining 30 lL reaction mixture comprising 200 lg calf
thymus histones (Sigma-Aldrich), HAT assay buffer
(50 mM Tris/HCl pH 8.0, 50 mM KCl, 0.1 mM EDTA,
1 mM dithiothreitol, 5% v/v glycerol, 1 mM phenylmethane-
sulfonyl fluoride and 10 mM sodium butyrate), 2 lL of 3H-
acetyl CoA (0.1 mCimL1; Perkin Elmer, Waltham, MA,
USA) and purified Rv3423.1 protein (0–1000 ng) were
incubated at 30 °C for 30 min. Rv2059, a recombinant
MTB protein purified under similar conditions, was used as
a mock control. Each sample was transferred into the P-81
cellulose filter well and incubated for 10 min. The wells
were washed five times with 100 lL of 50 mM sodium
bicarbonate (pH 9.0) for 5 min each. Chilled acetone
(50 lL) was added to the wells and incubated overnight at
25 °C. Liquid scintillation cocktail (80 lL) was added,
mixed and incubated at 25 °C for 4 h. The 3H radiation
was recorded as 1 min counts using a scintillation counter
(Perkin Elmer).
Detection of NADH generation
A histone acetyl transferase activity assay kit (Abcam) was
used according to the manufacturer’s instructions. Increas-
ing concentrations of purified recombinant Rv3423.1 pro-
tein in PBS were added for each assay in a 96-well plate at
a final volume of 40 lL. To each well, 68 lL assay mix
containing 50 lL of 29 HAT assay buffer, 5 lL HAT sub-
strate I, 5 lL HAT substrate II and 8 lL NADH-generat-
ing enzyme were added. The plate was then incubated at
37 °C for 2 h, and samples were read in an iMark micro-
plate absorbance reader (Bio-Rad) at 450 nm. A nuclear
extract (50 lg) from HeLa cells provided in the HAT assay
kit served as a positive control. The recombinant protein
(Rv2059) from MTB was used as the mock control. The
background reading for the negative control (buffer and
substrate) was subtracted from all the readings.
Determination of HAT enzyme activity by ELISA
The HAT enzyme activity was determined using an ELISA
HAT assay kit (Upstate Biotechnology, Lake Placid, NY,
USA) according to the manufacturer’s instructions. Briefly,
streptavidin-coated strip plates were incubated with biotiny-
lated histone H3 peptide. Rv3423.1 protein (250 ngmL1)
was used for the assay. Acetyl histone H3 and HeLa
nuclear extract were used as positive controls. Anacardic
acid, a HAT inhibitor (10 lM), was used to further confirm
the HAT activity. The HAT reaction was carried out in the
HAT buffer provided in the assay kit, and incubated at
30 °C, and the strip plates were washed and probed for
acetylation of the histone peptides using an antibody
against a-acetyl lysine provided in the kit for 90 min. Then
the wells were washed with HAT wash buffer, and tetram-
ethyl benzidine substrate mixture was added to each well
before incubation in the dark for 10 min. Finally, 0.1 M
sulfuric acid was added to stop the reaction, and the
enzyme activity was measured on a microplate reader (exci-
tation 450 nm, emission 570 nm), and expressed as ng
acetylated histone per mg enzyme. The 450 nm absorbance
values were subtracted from the 570 nm values to remove
any well-to-well variation.
Immuno dot blot
The HAT reaction cocktail was prepared as described in
the previous experiment. The reaction was incubated for
2 h at 30 °C. The reaction mix (20 lL) was spotted onto
activated poly(vinylidene difluoride) membrane, and then
allowed to dry for 30 min. The dried membrane was incu-
bated in blocking solution (5% BSA in Tris-buffered Saline
with Tween 20) for 1 h. The membrane was then incubated
with antibody against acetyl H3 K9/K14 (Abcam) for 2 h,
followed by alkaline phosphatase-conjugated secondary
antibody (Sigma-Aldrich) for 1 h, then incubated in nitro-
blue tetrazolium chloride (NBT) and 5-bromo-4-chloro-30-
indolyphosphate p-toluidine salt (BCIP) substrate solution
until spots were visible, and an image was captured using
VersaDoc imager (Bio-Rad, Hercules, CA, USA).
Nuclear localization of Rv3423.1
The Rv3423.1 gene was cloned into mammalian expression
vector pDsRed-Express-C1 (Invitrogen) as a C-terminal
fusion protein. The histone H1–eGFP fusion construct was
used as the nuclear marker. THP-1 monocytes (106 cells/
100 lL) were mixed with 0.5 lg plasmid DNA from both
constructs, and electroporated using Nucleofector (Lonza,
Germany). After electroporation, 500 lL of pre-warmed
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culture medium containing 20 ngmL1 phorbol 12-myris-
tate 13-acetate was added to the cells, and the cell suspen-
sion was transferred into 96-well glass-bottomed plates
(Perkin Elmer). The cells were incubated at 37 °C in a CO2
incubator for 12 h post-transfection before assaying for
gene expression. Co-localization of histone H1–eGFP and
Rv3423.1–DsRed was analyzed by confocal fluorescence
microscopy using a Nikon Eclipse Ti-S microscope. Image
capture, Z-stacking and calculation of co-localization coef-
ficients were performed using NIS ELEMENTS software
(Nikon) under identical exposure and gain settings.
Generation of polyclonal antibodies and
co-immunoprecipitation
Native Rv3423.1 protein was purified as described above,
and used to generate polyclonal antibodies. Procedures
involving animals were performed in accordance with the
guidelines of the Institute Animal Ethics Committee, Rajiv
Gandhi Centre for Biotechnology (Thiruvananthapuram,
India). The primary dose (300 lg protein in Titermax Gold
adjuvant; Sigma-Aldrich) was administered intradermally
into the interscapular area at multiple sites (10–20 lL per
site) of two New Zealand White female rabbits, followed
by a booster injection on the 28th day. Serum was collected
on the 60th day, and IgG was purified from the serum
using AminoLink Plus Resin (Thermo Scientific) according
to the manufacturer’s instructions. The in vivo interaction
between Rv3423.1 and histone H3 was analyzed by co-
immunoprecipitation experiments. THP-1 macrophages
infected with MTB were treated with lysis buffer (50 mM
Tris pH 8.0, 100 mM NaCl, 20 mM NaF, 50 mM KH2PO4,
1% Triton X-100, 10% glycerol and 0.1 mM dithiothreitol)
containing protease inhibitor cocktail (Sigma-Aldrich).
Antibodies against histone H3 (Abcam) or Rv3423.1
(raised in-house) were captured using Protein A Sepharose
beads. Lysates (500 lg/500 lL) were sonicated, clarified,
and resuspended in binding buffer (50 mM Tris/HCl pH
8.0, 100 mM KCl, 0.1 mM EDTA, 0.2% NP-40, 2.5% glyc-
erol and 1 mM dithiothreitol). The immune complexes
bound to the beads were collected and washed using wash
buffer (100 mM Tris/HCl pH 8.0, 100 mM NaCl, 0.5% NP-
40), and bound proteins on the beads were resuspended in
SDS/PAGE sample buffer. The immunoprecipitates were
resolved by SDS/PAGE and transferred to polyvinylidene
difluoride membranes (GE Healthcare), which were probed
with the purified antibodies against Rv3423.1 or antibody
against histone H3 and developed using a chemilumines-
cence detection kit (GE Healthcare).
Quantitative PCR to detect intracellular Rv3423.1
Infection of macrophages with M. tuberculosis, total
RNA extraction and cDNA preparation were performed
as described above. The relative expression of Rv3423.1
was evaluated by quantitative real-time PCR using SYBR
Green Supermix kit (Bio-Rad). The PCR conditions were
as follows: 60 °C for 20 min, 95 °C for 4 min, 95 °C for
10 s, 60 °C for 30 s, 72 °C for 30 s (30 cycles), then 55–
95 °C with a 0.5 °C increment (melting curve). Fold
changes in expression levels at various time points were
calculated relative to the endogenous gene Sigma Factor
A (SigA) using the 2DDCT method [39].
Preparation of MTB cell lysates and culture filtrates for
Western blot analysis
MTB H37Rv and H37Ra strains were grown in liquid med-
ium for 7 days as described above, and the cells were har-
vested by centrifugation at 1000 g for 10 min at 25 C.
The culture supernatant was recovered after filtration
through 0.22 lm pore-size filters (Millipore), and concen-
trated by trichloroacetic acid precipitation. The cell pellet
was washed and resuspended in PBS followed by rupture
using 0.1 mm glass beads (Sigma-Aldrich) for three 1 min
pulses at 2500 rpm in a mini bead beater (Biospec, Bartles-
ville, OK, USA). The lysate was recovered after centrifuga-
tion at 13 000 g for 30 min. Total protein concentrations
were determined by the Bradford assay (Sigma-Aldrich),
and 30 lg samples were subjected to SDS/PAGE. Western
blot analysis was performed using polyclonal antibodies
against Rv3423.1 and developed using a chemiluminescence
detection kit.
In vitro growth and intracellular survival of recombinant
M. smegmatis carrying the Rv3423.1 gene
The Rv3423.1 gene was amplified from MTB H37Rv geno-
mic DNA as described above except that the forward and
reverse primers contained BamHI and HindIII restriction
sites, respectively, and an N-terminal FLAG coding sequence
to assist protein detection. The gene was cloned into
mycobacterial constitutive expression vector pBEN using the
above-mentioned restriction sites in the mutiple cloning site
downstream of the mycobacterial hsp60 promoter. Electro-
poration of M. smegmatis mc2155 competent cells was
performed using a Gene Pulser electroporation system
(Bio-Rad) at a voltage of 1.5 kV, resistance of 200 Ω and
capacitance of 25 lF. The recombinant cells were selected on
Middlebrook 7H10 agar plates containing 10% oleate-albu-
min-dextrose-catalase with 25 lgmL1 kanamycin. In vitro
growth of recombinant M. smegmatis and M. smegmatis
carrying the control vector was determined by measuring the
attenuance at 600 nm. To analyze the intracellular survival
in macrophages, THP-1 cells were seeded in 90 mm tissue
culture-grade Petri plates at a seeding density of 2 million
cells per plate in antibiotic-free RPMI-1640 medium, and
induced using 20 ngmL1 phorbol 12-myristate 13-acetate
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24 h prior to infection. Bacterial suspension was added to
the macrophage cells at a multiplicity of infection of 20 : 1.
Internalization was allowed to proceed for 1 h at 37 °C and
5% CO2. After phagocytosis, each well was washed three
times with PBS containing gentamycin (10 lgmL1) to
remove extracellular bacteria. Fresh medium was added to
the wells and incubated at 37 °C for 72 h. Every 6 h, the
medium was removed, macrophage cells were lysed with
100 lL distilled water, and the lysate was serially diluted and
plated onto plates containing LB agar (HiMedia, Mumbai,
India) with 25 lgmL1 kanamycin, and incubated at 37 °C
for 3 days. The experiment was performed in triplicate, and
a survival curve was plotted.
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